These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1823838)
21. Role of [131I]metaiodobenzylguanidine therapy in carcinoids. Hoefnagel CA; Taal BG; Valdés Olmos RA J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678 [TBL] [Abstract][Full Text] [Related]
22. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma. Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators. Lumbroso J; Hartmann O; Schlumberger M J Nucl Biol Med (1991); 1991; 35(4):220-3. PubMed ID: 1823822 [TBL] [Abstract][Full Text] [Related]
24. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo"). Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828 [TBL] [Abstract][Full Text] [Related]
27. Role of [131I]metaiodobenzylguanidine therapy in medullary thyroid carcinoma. Hoefnagel CA; Delprat CC; Valdés Olmos RA J Nucl Biol Med (1991); 1991; 35(4):334-6. PubMed ID: 1823851 [TBL] [Abstract][Full Text] [Related]
28. Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma: seven years after. Hör G; Maul FD; Kornhuber B; Schwabe D; Hesse J; Manegold KH; Baüm RP; Gerein V J Nucl Biol Med (1991); 1991; 35(4):207-15. PubMed ID: 1823820 [TBL] [Abstract][Full Text] [Related]
29. [Diagnosis and therapy of neuroectodermal tumors]. Adolph J; Kimmig B Radiologe; 1989 Jan; 29(1):32-42. PubMed ID: 2537501 [TBL] [Abstract][Full Text] [Related]
36. Low-dose iodine-131 metaiodobenzylguanidine therapy for patients with malignant pheochromocytoma and paraganglioma: single center experience. Shilkrut M; Bar-Deroma R; Bar-Sela G; Berniger A; Kuten A Am J Clin Oncol; 2010 Feb; 33(1):79-82. PubMed ID: 19704370 [TBL] [Abstract][Full Text] [Related]
37. Preliminary results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid tumors. Colombo L; Vignati A; Lomuscio G; Dottorini ME J Nucl Biol Med (1991); 1991; 35(4):352-4. PubMed ID: 1823856 [TBL] [Abstract][Full Text] [Related]
38. Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients. Klingebiel T; Feine U; Treuner J; Reuland P; Handgretinger R; Niethammer D J Nucl Biol Med (1991); 1991; 35(4):216-9. PubMed ID: 1823821 [TBL] [Abstract][Full Text] [Related]
39. Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma. Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C J Clin Endocrinol Metab; 1991 Feb; 72(2):455-61. PubMed ID: 1991814 [TBL] [Abstract][Full Text] [Related]
40. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine. Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]